BridgeMD
New treatment option for Lateral Epicondylitis
Official title High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis
ClinicalTrials.gov ID: NCT07342426
What this study is testing
- What it's testing
- High-intensity laser therapy has gained increasing attention in recent years as a therapeutic modality. It is a non-invasive treatment that can reduce pain, increase local blood circulation, and promote tissue repair.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients diagnosed with lateral epicondylitis by physician
- Disease duration of less than three months
- Adults aged above 18 years with full decision-making capacity
You likely can't join if
- Patients who have received treatments other than standard treatment to the affected area within past three months
- Patients with contraindication for rehabilitation therapy
- Photosensitivity
- Sensory impairment
- Implanted cardiac pacemaker
- Pregnancy
See the full eligibility criteria
- Patients diagnosed with lateral epicondylitis by physician
- Disease duration of less than three months
- Adults aged above 18 years with full decision-making capacity
- Patients who have received treatments other than standard treatment to the affected area within past three months
- Patients with contraindication for rehabilitation therapy
- Photosensitivity
- Sensory impairment
- Implanted cardiac pacemaker
- Pregnancy
- Malignancy
- Patients with a history of surgery on the affected elbow
- Patients with cervical radiculopathy
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.